Clinical Trial

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 22, 2024 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators aim to investigate a possible role for radiotherapy in good prognosis bladder cancer patients has been identified as a possible alternative to cystectomy, especially for patients non-eligible for surgery but has yet to be fully explored.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-07.
Trial Details
NCT Number NCT06310369
Lead Sponsor European Organisation for Research and Treatment of Cancer - EORTC
Conditions Bladder Cancer
Enrollment 50 participants
Start Date 2025-03-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2030-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-22